ATE282606T1 - Indolderivate als serotonergische mittel - Google Patents

Indolderivate als serotonergische mittel

Info

Publication number
ATE282606T1
ATE282606T1 AT99918860T AT99918860T ATE282606T1 AT E282606 T1 ATE282606 T1 AT E282606T1 AT 99918860 T AT99918860 T AT 99918860T AT 99918860 T AT99918860 T AT 99918860T AT E282606 T1 ATE282606 T1 AT E282606T1
Authority
AT
Austria
Prior art keywords
indole derivatives
serotonergic agents
serotonergic
agents
indole
Prior art date
Application number
AT99918860T
Other languages
English (en)
Inventor
Michael Gerard Kelly
Young Hee Kang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE282606T1 publication Critical patent/ATE282606T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99918860T 1998-04-29 1999-04-28 Indolderivate als serotonergische mittel ATE282606T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6904598A 1998-04-29 1998-04-29
PCT/US1999/009129 WO1999055694A1 (en) 1998-04-29 1999-04-28 Indolyl derivatives as serotonergic agents

Publications (1)

Publication Number Publication Date
ATE282606T1 true ATE282606T1 (de) 2004-12-15

Family

ID=22086373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918860T ATE282606T1 (de) 1998-04-29 1999-04-28 Indolderivate als serotonergische mittel

Country Status (13)

Country Link
EP (1) EP1075471B1 (de)
JP (1) JP2002513015A (de)
CN (1) CN1144800C (de)
AR (1) AR015037A1 (de)
AT (1) ATE282606T1 (de)
AU (1) AU3667699A (de)
CA (1) CA2330436A1 (de)
DE (1) DE69921983T2 (de)
DK (1) DK1075471T3 (de)
ES (1) ES2232132T3 (de)
PT (1) PT1075471E (de)
TW (1) TW528754B (de)
WO (1) WO1999055694A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291646B2 (en) 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
WO2003006455A1 (en) * 2001-07-11 2003-01-23 Eli Lilly And Company Pharmaceutical compounds with serotonin receptor activity
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
BRPI0616459A2 (pt) * 2005-09-29 2011-06-21 Wyeth Corp compostos das fórmulas i, ii, e iii; processos para o tratamento ou para a prevenção de: um estado de saúde com melhora devido à recaptação de monoamina; pelo menos um sintoma vasomotor; pelo menos um distúrbio depressivo; pelo menos uma disfunção sexual; para a prevenção de dor; de distúrbio gastrointestinal ou genitourinário; de sìndrome de fadiga crÈnica; de sìndrome de fibromialgia; de esquizofrenia; e uso de um composto
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
WO2009111736A1 (en) 2008-03-06 2009-09-11 Aquabeam Llc Tissue ablation and cautery with optical energy carried in fluid stream
WO2014127242A2 (en) 2013-02-14 2014-08-21 Procept Biorobotics Corporation Aquablation aquabeam eye surgery methods and apparatus
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
JP6080872B2 (ja) 2012-02-29 2017-02-15 プロセプト バイオロボティクス コーポレイション 自動化された画像誘導組織切除および治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
ES2232132T3 (es) 2005-05-16
AR015037A1 (es) 2001-04-11
TW528754B (en) 2003-04-21
DK1075471T3 (da) 2005-01-17
JP2002513015A (ja) 2002-05-08
CN1144800C (zh) 2004-04-07
WO1999055694A1 (en) 1999-11-04
EP1075471B1 (de) 2004-11-17
DE69921983D1 (de) 2004-12-23
DE69921983T2 (de) 2005-04-07
EP1075471A1 (de) 2001-02-14
CA2330436A1 (en) 1999-11-04
AU3667699A (en) 1999-11-16
PT1075471E (pt) 2005-02-28
CN1307574A (zh) 2001-08-08

Similar Documents

Publication Publication Date Title
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
ATE359275T1 (de) Substituierte bizyclische derivate verwendbar als antitumor mittel
ATE219485T1 (de) N-benzyl-2-phenylindole als östrogene mittel
DE69920009D1 (de) Isothiazole derivate verwendbar als antikrebsmittel
ATE219490T1 (de) Indazoleamid-verbindungen als serotoninergene mittel
ATE315036T1 (de) 2,4-diaminopyrimidinderivate als immunosuppressiva
ATE308519T1 (de) 2,3-substituierte indolverbindungen als cox-2 inhibitoren
ATE259362T1 (de) Indolylpiperidinderivate als antihistaminische und antiallergische mittel
DE60028085D1 (de) Piperidinyloxy- und pyrrolidinyloxyphenyloxazolidinone als antibakterielle mittel
DE69917451D1 (de) Sulfonylbenzolverbindungen als analgetische und entzündungshemmende mittel
ATE282606T1 (de) Indolderivate als serotonergische mittel
DE50011908D1 (de) 16-hydroxyestratriene als selektiv wirksame estrogene
ATE299876T1 (de) Indolderivate
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
IS6434A (is) Nýjar indól afleiður
NO20020306D0 (no) Indolderivater
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel
ATE236150T1 (de) (4-piperidinyl)-1h-2-benzopyran derivate verwendbar als antipsychotische mittel
ATE321761T1 (de) Indolylpiperidinderivate als antihistaminische und antiallergische mittel
DK1073651T3 (da) Indolylderivater som serotonerge midler
DE69908330D1 (de) 5-heteroaryl-substituierte indole
ATE287708T1 (de) 1-amino-alkylcyclohexanederivate als trypanocide mittel
ATE268754T1 (de) N-substituierte indoline als östrogene mittel
ATE252090T1 (de) Dihydrotriazolonderivate als pestizide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1075471

Country of ref document: EP

REN Ceased due to non-payment of the annual fee